HAL (France)open access
Effect of alirocumab on individuals with type 2 diabetes, high triglycerides, and low high-density lipoprotein cholesterol
1, Usual care, Triglycerides, Non-HDL-C, ODYSSEY, 2, Alirocumab, PCSK9
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 322568
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.